Simultaneous Molecular and Hypoxia Imaging of Brain Tumors In Vivo Using Spectroscopic Photoacoustic Tomography
Abstract
Noninvasive molecular and functional imaging in vivo is promising for detecting and monitoring various physiological conditions in animals and ultimately humans. To this end, we present a novel noninvasive technology, spectroscopic photoacoustic tomography (SPAT), which offers both strong optical absorption contrast and high ultrasonic spatial resolution. Optical contrast allows spectroscopic separation of signal contributions from multiple optical absorbers (e.g., oxyhemoglobin, deoxyhemoglobin, and a molecular contrast agent), thus enabling simultaneous molecular and functional imaging. SPAT successfully imaged with high resolution the distribution of a molecular contrast agent targeting integrin overexpressed in human U87 glioblastomas in nude mouse brains. Simultaneously, SPAT also imaged the hemoglobin oxygen saturation and the total hemoglobin concentration of the vasculature, which revealed hypoxia in tumor neovasculature. Therefore, SPAT can potentially lead to better understanding of the interrelationships between hemodynamics and specific biomarkers associated with tumor progression.
Additional Information
© 2008 IEEE. Manuscript received June 1, 2007; revised September 5, 2007. This work was supported in part by the National Institutes of Health under Grants R01 EB000712 and R01 NS46214.Attached Files
Published - 04445026.pdf
Files
Name | Size | Download all |
---|---|---|
md5:adf6ddd8d2e389037cd26ef314860f57
|
548.2 kB | Preview Download |
Additional details
- Eprint ID
- 70615
- Resolver ID
- CaltechAUTHORS:20160927-140749582
- R01 EB000712
- NIH
- R01 NS46214
- NIH
- Created
-
2016-09-28Created from EPrint's datestamp field
- Updated
-
2021-11-11Created from EPrint's last_modified field